We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$8.92B
Cap. Flow
+$6.38B
Cap. Flow %
38.87%
Top 10 Hldgs %
11.97%
Holding
501
New
64
Increased
117
Reduced
241
Closed
32

Top Buys

Rank Stock Value
1
PINS icon
Pinterest
PINS
+$181M
2
CRWD icon
CrowdStrike
CRWD
+$173M
3
RNG icon
RingCentral
RNG
+$166M
4
SNPS icon
Synopsys
SNPS
+$158M
5
WCN
Waste Connections
WCN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Healthcare 20.91%
3 Industrials 14.05%
4 Consumer Discretionary 13.18%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRI icon
426
Stoneridge
SRI
$213M
$3.75M 0.02%
123,868
-6,000
-5% -$156K
CVS icon
427
CVS Health
CVS
$124B
$3.71M 0.02%
54,300
-2,100
-4% -$137K
AX icon
428
Axos Financial
AX
$5.56B
$3.67M 0.02%
97,642
-4,700
-5% -$149K
VRTX icon
429
Vertex Pharmaceuticals
VRTX
$138B
$3.64M 0.02%
15,400
-600
-4% -$138K
PLUS icon
430
ePlus
PLUS
$2.4B
$3.63M 0.02%
82,666
-2,600
-3% -$104K
QTS
431
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.6M 0.02%
58,262
-2,600
-4% -$163K
LOW icon
432
Lowe's Companies
LOW
$115B
$3.48M 0.02%
21,700
-800
-4% -$130K
AKAM icon
433
Akamai
AKAM
$15.1B
$3.43M 0.02%
32,700
-1,200
-4% -$126K
BOX icon
434
Box
BOX
$4.83B
$3.38M 0.02%
187,409
-8,600
-4% -$150K
EGRX
435
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.36M 0.02%
72,136
-3,700
-5% -$173K
GIII icon
436
G-III Apparel Group
GIII
$1.17B
$3.21M 0.02%
135,158
-6,400
-5% -$119K
QRVO icon
437
Qorvo
QRVO
$9.07B
$3.18M 0.02%
19,100
-600
-3% -$88.3K
HCSG icon
438
Healthcare Services Group
HCSG
$1.5B
$3.11M 0.02%
110,762
-5,600
-5% -$135K
CBRL icon
439
Cracker Barrel
CBRL
$1.22B
$3.06M 0.02%
23,199
-900
-4% -$116K
ZBH icon
440
Zimmer Biomet
ZBH
$18.7B
$3.02M 0.02%
20,188
-721
-3% -$102K
CNO icon
441
CNO Financial Group
CNO
$5.25B
$2.88M 0.02%
129,751
-6,100
-4% -$124K
HTH icon
442
Hilltop Holdings
HTH
$2.25B
$2.88M 0.02%
104,780
-5,000
-5% -$120K
PI icon
443
Impinj
PI
$5.27B
$2.88M 0.02%
68,693
-3,500
-5% -$122K
CTRE icon
444
CareTrust REIT
CTRE
$9.22B
$2.87M 0.02%
129,259
-6,100
-5% -$120K
GDOT icon
445
Green Dot
GDOT
$760M
$2.84M 0.02%
50,904
-2,400
-5% -$136K
CMI icon
446
Cummins
CMI
$77.2B
$2.84M 0.02%
12,500
-400
-3% -$89.8K
DPZ icon
447
Domino's
DPZ
$11.3B
$2.76M 0.02%
7,200
-100
-1% -$39.3K
PRAA icon
448
PRA Group
PRAA
$716M
$2.72M 0.02%
68,673
-3,500
-5% -$139K
NET icon
449
Cloudflare
NET
$99.3B
$2.67M 0.02%
35,200
-1,200
-3% -$78.7K
SSNC icon
450
SS&C Technologies
SSNC
$19.6B
$2.66M 0.02%
36,600
-1,300
-3% -$87.1K

Similar funds

Carillon Tower Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Carillon Tower Advisers held 501 positions worth $16.4B, up 119% from $7.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Carillon Tower Advisers deployed $6.38B of net new capital in Q4 2020, opening 64 new positions and adding to 117 existing holdings. Its largest new stake was Pinterest: 3,021,131 shares worth $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Q2 Holdings, an estimated $278M trimmed.

  • Carillon Tower Advisers's largest Q4 2020 buy was Pinterest: 3,021,131 shares worth $199M.
  • Carillon Tower Advisers added most to CrowdStrike in Q4 2020, an estimated $173M increase.
  • Carillon Tower Advisers's biggest Q4 2020 reduction was Q2 Holdings, cutting an estimated $278M.
  • Carillon Tower Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, selling an estimated $31.6M.
  • Carillon Tower Advisers's ten largest holdings make up 12% of its $16.4B portfolio in Q4 2020.
  • Carillon Tower Advisers opened 64 new positions and closed 32 in Q4 2020.
  • Carillon Tower Advisers's portfolio value rose 119% quarter-over-quarter to $16.4B.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.